Sunday 11 October 2026 Export all BMY data to Excel Powerpack

Bristol Myers Squibb Company

BMY Healthcare Drug Manufacturers General

Bristol Myers Squibb Company’s revenue for fiscal 2025 (year ended December 2025) was $48.2 billion, roughly unchanged from fiscal 2024. In the quarter to June 2026, revenue grew 5.74%, EPS grew 153.1%, free cash flow fell 13.2% and total debt fell 12.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.

59.12 0.46 −0.77%

Follow BMY

Alert me

Market cap: $121.7B
P/E: 13.0×
Fwd P/E: 11.2×
Dividend yield: 4.26%
F-score: 8/9
Altman Z: 2.14
Beneish M: −2.69
Dividend safety: 63/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	33.74%	40.43%	38.75%	46.63%
Piotroski F-Score Full definition →		7	8	7	7
ROA Full definition →		6.34%	7.72%	8.13%	10.18%
ROIC Full definition →		9.83%	11.01%	11.09%	13.69%
Return on Tangible Assets Full definition →		40.69%	52.19%	46.31%	52.41%
Average Days of Receivables Full definition →		86.79	86.44	70.53	78.31
Free Cash Flow per Share Full definition →		7.52	6.32	5.84	5.60
Free Cash Flow Full definition →		15,302.00	12,845.00	11,908.00	11,440.00
Capital Expenditures Full definition →		(1,319.00)	(1,311.00)	(1,398.00)	(1,342.00)
Other line items
Cash ROIC Full definition →		18.20%	17.29%	15.87%	14.95%
Accounts Receivable Turnover Full definition →		4.28	4.35	4.81	4.48
Accounts Payable Turnover Full definition →		3.78	3.88	3.48	3.06
Inventory Turnover Full definition →		4.81	5.31	5.28	5.36
Average Days of Payables Full definition →		106.82	93.63	107.89	103.40
Days of Inventory on Hand Full definition →		68.71	70.45	70.23	68.06
Tax Rate Full definition →		(0.25)	(0.24)	(0.24)	(0.22)
Research and Development Expense of Revenue Full definition →		21.98%	20.65%	21.33%	21.80%
Selling, General and Administrative Expense of Revenue Full definition →		15.04%	15.08%	15.06%	15.07%
Share Based Compensation of Revenue Full definition →		1.12%	1.15%	1.14%	1.12%
Operating CF/Net income Full definition →		2.75	2.01	1.83	1.38
Depreciation/Fixed assets Full definition →		0.67	0.53	0.47	0.41
Capex/Depreciation Full definition →		(0.27)	(0.33)	(0.39)	(0.42)
Revenue per Share Full definition →		23.59	23.69	23.79	24.09
Operating CF per Share Full definition →		8.16	6.96	6.53	6.26
Capex per Share Full definition →		(0.65)	(0.64)	(0.69)	(0.66)
Capex to Sales Full definition →		0.03	0.03	0.03	0.03

Show all line items

Columns are period end dates

Stockrow Weekly